Bioprostethic mitral valve thrombosis due to oral contraceptive drug use and management with ultra-slow thrombolytic therapy
Blood Coagulation and Fibrinolysis, cilt.27, sa.2, ss.220-222, 2016 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 27 Sayı: 2
- Basım Tarihi: 2016
- Doi Numarası: 10.1097/mbc.0000000000000420
- Dergi Adı: Blood Coagulation and Fibrinolysis
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.220-222
- Anahtar Kelimeler: bioprosthetic valve, oral contraceptive drugs, thrombolytic therapy, thrombosis, tissue-type plasminogen activator
- Kütahya Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Prosthetic valve thrombosis is a severe complication, which usually occurs in inadequately anticoagulated patients. Mechanical valve thrombosis is more common than bioprosthetic valve thrombosis (BVT). Oral contraceptive drugs are associated with increased risk of thromboembolism in women. The possible association between oral contraceptive drug use and BVT has never been reported before. We present a case of obstructive BVT occurring after the use of an oral contraceptive drug and successful management with ultra-slow thrombolytic therapy.